MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an update. On December 10, 2025, MAIA Biotechnology announced a significant advancement in the ...

Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...

The final draft of the FY 2026 National Defense Authorization Act (NDAA) includes the proposed BIOSECURE Act (the Act), which would place ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint ...

The latest insider buying arrives as ateganosine continues to deliver encouraging results. These outcomes have strengthened internal and external confidence that MAIA’s novel telomere-targeting ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has issued an update. Shanghai Henlius Biotech, Inc. announced the approval of phase 2/3 ...

Depth Analysis of Bioseparation Systems Market, Highlighting Trends, Technologies, ESG Insights, and Growth Potential Through ...

Sana Biotechnology (SANA) shares have caught the eye lately, with investors tracking shifts in the biotech landscape and the company’s ongoing pipeline developments. There is growing interest as Sana ...

Givaudan’s Zensera Launch: In June 2025, Givaudan introduced Zensera, a lemon balm extract clinically proven to enhance calmness and cognitive performance at a low dosage, expanding opportunities in ...

Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in ...

The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will deliver the keynote address at the 2026 MDA ...

The National Biotechnology Research and Development Agency has convened a multi-stakeholder review and validation workshop to update and strengthen the National Biotechnology Policy and reposition ...